Clopidogrel resistance test for stroke patients with stent
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial is for people who have had a stroke caused by narrowed arteries in the brain and are scheduled for a stent placement. It looks at whether a blood test can help predict who might have another stroke despite taking common blood thinners.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You had a stroke due to narrowing of arteries in the brain (not from a heart problem or unknown cause)
- You are scheduled to get a stent in a brain artery
- After the stent, you will take aspirin and clopidogrel (Plavix) for at least 3 months
- You do not have certain heart conditions like atrial fibrillation, or a bleeding disorder
- You are not pregnant or planning to become pregnant, and do not have cancer or a life expectancy under 1 year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a new blood test can help predict how well Plavix (clopidogrel) works in people who have had a mild stroke or a high-risk mini-stroke (TIA). If the test works, doctors may be able to adjust treatment sooner to prevent another stroke.
This trial tests a combination of two blood thinners (antiplatelet drugs) to see if they work better than one in people who had a mild stroke caused by a narrowed artery in the brain. If you had a recent first stroke and are otherwise healthy, you may be able to join.
This study tests if combining the blood thinner clopidogrel with either atorvastatin or rosuvastatin (both cholesterol-lowering drugs) works better for people who have had a mild first-time stroke in the small blood vessels of the brain. The goal is to find a safe and effective treatment regimen.
This trial is testing whether combining aspirin with either cilostazol or clopidogrel is more effective at preventing another stroke after a minor stroke or TIA. It is for people who had their first mild stroke or TIA and started a blood thinner within 24 hours.
This study tests whether guiding antiplatelet medication with a blood test can help prevent another stroke or TIA. It looks at people who have had a mild stroke or high-risk TIA within the last 48 hours.
This trial looks at whether using clopidogrel by itself (without aspirin) works for people after a new drug-eluting stent, based on a blood test of how your body processes the drug. It may help reduce “extra blood-thinning” if you have a certain genetic type that responds well to clopidogrel.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.